Literature DB >> 25844362

The effect of pharmacist-led medication review in high-risk patients in the emergency department: an evaluation protocol.

Corinne M Hohl1, Kimberlyn McGrail2, Boris Sobolev3.   

Abstract

BACKGROUND: Adverse drug events are unintended and harmful events related to medication use. They are a leading cause of visits to the emergency department, unplanned admissions to hospital and death. Adverse drug events can be misdiagnosed in the emergency department, resulting in treatment delays. Our objective was to describe a process to evaluate the effect of pharmacist-led medication review in high-risk patients in the emergency department on the number of days these patients subsequently spent in hospital within 30 days of their index visit.
METHODS: We describe the evaluation of a prospective multicentre quality improvement program. During the evaluation period, triage nurses will flag incoming patients to the emergency department at high risk for adverse drug events by applying a clinical decision rule consisting of 4 variables (comorbid conditions, antibiotic use within 7 days, medication changes within 28 days and age). Consecutive eligible patients will be enrolled in the study and systematically allocated to either a pharmacist-led medication review group or a control group. In the intervention group, pharmacists will collect best-possible medication histories, review the patient's medications for appropriateness and adverse drug events, and communicate the results of their medication review to patients, caregivers and physicians. In the control group, nurses will start medication reconciliation by collecting best-possible medication histories, and physicians will refer patients to onsite pharmacists for specific medication management questions as needed. Health outcomes will be assessed using anonymized data linkage to administrative health databases. The primary outcome will be the percent days spent in hospital over a 30-day period.
INTERPRETATION: This protocol describes the methods for evaluating the effect of pharmacist-led medication review in high-risk patients in the emergency department on use of health services, and highlights the methodological challenges that will be encountered. We plan to disseminate the results of this evaluation through articles published in peer-reviewed journals, presentations at scientific meetings and briefing notes to institutional, provincial and national stakeholders.

Entities:  

Year:  2015        PMID: 25844362      PMCID: PMC4382036          DOI: 10.9778/cmajo.20140010

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  19 in total

1.  Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases.

Authors:  Lesley H Curtis; Bradley G Hammill; Eric L Eisenstein; Judith M Kramer; Kevin J Anstrom
Journal:  Med Care       Date:  2007-10       Impact factor: 2.983

2.  Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study.

Authors:  Peter J Zed; Riyad B Abu-Laban; Robert M Balen; Peter S Loewen; Corinne M Hohl; Jeffrey R Brubacher; Kerry Wilbur; Matthew O Wiens; Leslie J Samoy; Katie Lacaria; Roy A Purssell
Journal:  CMAJ       Date:  2008-06-03       Impact factor: 8.262

3.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

Authors:  Jerry H Gurwitz; Terry S Field; Leslie R Harrold; Jeffrey Rothschild; Kristin Debellis; Andrew C Seger; Cynthia Cadoret; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

4.  Outcomes of emergency department patients presenting with adverse drug events.

Authors:  Corinne M Hohl; Bohdan Nosyk; Lisa Kuramoto; Peter J Zed; Jeffrey R Brubacher; Riyad B Abu-Laban; Samuel B Sheps; Boris Sobolev
Journal:  Ann Emerg Med       Date:  2011-02-26       Impact factor: 5.721

5.  Clinical decision rules to improve the detection of adverse drug events in emergency department patients.

Authors:  Corinne M Hohl; Eugenia Yu; Garth S Hunte; Jeffrey R Brubacher; Faegheh Hosseini; Chelsea P Argent; Winnie W Y Chan; Matthew O Wiens; Samuel B Sheps; Joel Singer
Journal:  Acad Emerg Med       Date:  2012-06       Impact factor: 3.451

6.  Do emergency physicians attribute drug-related emergency department visits to medication-related problems?

Authors:  Corinne M Hohl; Peter J Zed; Jeffrey R Brubacher; Riyad B Abu-Laban; Peter S Loewen; Roy A Purssell
Journal:  Ann Emerg Med       Date:  2009-12-11       Impact factor: 5.721

Review 7.  Medication review in hospitalised patients to reduce morbidity and mortality.

Authors:  Mikkel Christensen; Andreas Lundh
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 8.  Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis.

Authors:  Richard Holland; James Desborough; Larry Goodyer; Sandra Hall; David Wright; Yoon K Loke
Journal:  Br J Clin Pharmacol       Date:  2007-12-17       Impact factor: 4.335

9.  A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial.

Authors:  Ulrika Gillespie; Anna Alassaad; Dan Henrohn; Hans Garmo; Margareta Hammarlund-Udenaes; Henrik Toss; Asa Kettis-Lindblad; Håkan Melhus; Claes Mörlin
Journal:  Arch Intern Med       Date:  2009-05-11

Review 10.  Assessing the economic impact of adverse drug effects.

Authors:  Rosa Rodríguez-Monguió; María José Otero; Joan Rovira
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

View more
  8 in total

1.  Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers.

Authors:  Amira S A Said; Nadia Hussain
Journal:  Hosp Pharm       Date:  2017-05-01

2.  Quality of assessment and counselling offered by community pharmacists and medication sale without prescription to patients presenting with acute cardiac symptoms: a simulated client study.

Authors:  Tarek Seifaw Kashour; Abdulaziz Joury; Abdullah M Alotaibi; Mahmoud Althagafi; Aws S Almufleh; Ahmad Hersi; Lukman Thalib
Journal:  Eur J Clin Pharmacol       Date:  2015-11-23       Impact factor: 2.953

3.  Long-term use of proton pump inhibitors and prevalence of disease- and drug-related reasons for gastroprotection-a cross-sectional population-based study.

Authors:  Susanna M Wallerstedt; Johan Fastbom; Johannes Linke; Sigurd Vitols
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-11-16       Impact factor: 2.890

4.  Impact of early in-hospital medication review by clinical pharmacists on health services utilization.

Authors:  Corinne M Hohl; Nilu Partovi; Isabella Ghement; Maeve E Wickham; Kimberlyn McGrail; Lisa N Reddekopp; Boris Sobolev
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

5.  Methods for evaluating adverse drug event preventability in emergency department patients.

Authors:  Stephanie A Woo; Amber Cragg; Maeve E Wickham; David Peddie; Ellen Balka; Frank Scheuermeyer; Diane Villanyi; Corinne M Hohl
Journal:  BMC Med Res Methodol       Date:  2018-12-04       Impact factor: 4.615

6.  Prospective Validation of Clinical Criteria to Identify Emergency Department Patients at High Risk for Adverse Drug Events.

Authors:  Corinne M Hohl; Katherin Badke; Amy Zhao; Maeve E Wickham; Stephanie A Woo; Marco L A Sivilotti; Jeffrey J Perry
Journal:  Acad Emerg Med       Date:  2018-09       Impact factor: 3.451

7.  Preventable adverse drug events: Descriptive epidemiology.

Authors:  Stephanie A Woo; Amber Cragg; Maeve E Wickham; Diane Villanyi; Frank Scheuermeyer; Jeffrey P Hau; Corinne M Hohl
Journal:  Br J Clin Pharmacol       Date:  2020-01-10       Impact factor: 4.335

8.  The Utility of Different Data Standards to Document Adverse Drug Event Symptoms and Diagnoses: Mixed Methods Study.

Authors:  Erina Chan; Serena S Small; Maeve E Wickham; Vicki Cheng; Ellen Balka; Corinne M Hohl
Journal:  J Med Internet Res       Date:  2021-12-10       Impact factor: 5.428

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.